AB Corporate Bond ETF (NASDAQ:EYEG) Sees Large Drop in Short Interest

AB Corporate Bond ETF (NASDAQ:EYEG) saw a large drop in short interest in the month of October. As of October 30th, there was short interest totaling 43 shares, a drop of 95.5% from the October 15th total of 950 shares. Based on an average daily volume of 5,020 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

AB Corporate Bond ETF Stock Performance

NASDAQ:EYEG traded down $0.23 during mid-day trading on Tuesday, hitting $33.73. 35 shares of the company traded hands, compared to its average volume of 542. The stock’s fifty day moving average price is $33.80 and its 200-day moving average price is $34.87. AB Corporate Bond ETF has a one year low of $33.24 and a one year high of $36.46. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.01. The firm has a market cap of $26.99 million, a price-to-earnings ratio of -20.08 and a beta of 0.18.

AB Corporate Bond ETF Increases Dividend

The business also recently disclosed a monthly dividend, which was paid on Thursday, November 5th. Stockholders of record on Monday, November 2nd were given a dividend of $0.1460 per share. This represents a $1.75 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date of this dividend was Monday, November 2nd. This is an increase from AB Corporate Bond ETF’s previous monthly dividend of $0.1367. AB Corporate Bond ETF’s payout ratio is presently -102.38%.

About AB Corporate Bond ETF

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.